COMPANY
Outset Medical
Headquartered in San Jose, California, Outset operates across the United States and manufactures in North America. From company website Source · Oct 13, 2026
Since the raise (Jan 6, 2025): 34 of 34 open jobs were first seen after it.
Hiring
| Title | Location (from posting) | Employer posted | First seen |
|---|---|---|---|
| Market Director (West) | WestPac | Oct 22, 2026 | Oct 23, 2026 |
| Director of Strategic Accounts | Remote | Oct 22, 2026 | Oct 23, 2026 |
| Director of Strategic Accounts | Remote | Oct 22, 2026 | Oct 23, 2026 |
| Director of Strategic Accounts | Remote | Oct 22, 2026 | Oct 23, 2026 |
| Field Service Engineer II (Burlington/Central NC) | Burlington/Central NC | Oct 12, 2026 | Oct 13, 2026 |
Timeline
- Board tracked Radar started tracking this company’s job board (34 open jobs at last check). source ↗
- FDA FDA 510(k) clearance: Tablo Hemodialysis System (PN-0008000, PN-0006000U) — K253412, Jan 26, 2026. Applicant at approval: Outset Medical, Inc. source ↗
- Raise Private placement: $168.8M (total, as published), announced Jan 6, 2025. Source: SEC filing. source ↗
- Trial start —: EXtension of Tablo TrEatmeNt Duration Registry source ↗
- Trial start —: Comparative Outcome Measures of Patients Receiving Acute Renal ThErapy Study source ↗
- Trial start —: Home With TablO outcoMEs (HOME) Registry source ↗
- Trial start Not phased (device or behavioral study): The Study of Intradialytic Symptoms in Subjects Treated With Qd 500vs Qd 300 source ↗
- Trial start Not phased (device or behavioral study): The EvAluation of TaBlo In-CLinic and In-HOme source ↗
Open jobs 34
| Title | Location (from posting, not HQ) | Employer posted | First seen | Level |
|---|---|---|---|---|
| Market Director (West) | WestPac | Oct 22, 2026 | Oct 23, 2026 | Not stated |
| Director of Strategic Accounts | Remote | Oct 22, 2026 | Oct 23, 2026 | Not stated |
| Director of Strategic Accounts | Remote | Oct 22, 2026 | Oct 23, 2026 | Not stated |
| Director of Strategic Accounts | Remote | Oct 22, 2026 | Oct 23, 2026 | Not stated |
| Field Service Engineer II (Burlington/Central NC) | Burlington/Central NC | Oct 12, 2026 | Oct 13, 2026 | Mid |
| National Account Director | Remote | Oct 12, 2026 | Oct 13, 2026 | Senior |
| Staff Software Quality Engineer | San Jose, CA | Sep 30, 2026 | Oct 5, 2026 | Senior |
| Senior Software Quality Engineer | San Jose, CA | Sep 30, 2026 | Oct 5, 2026 | Senior |
| Field Service Engineer II (Los Angeles, CA) | Los Angeles, CA | Sep 29, 2026 | Oct 5, 2026 | Mid |
| Regional Manager, Clinical Excellence (Midwest) | Remote Location | Sep 28, 2026 | Oct 5, 2026 | Mid |
| Regional Manager, Clinical Excellence - West | Remote Location | Sep 28, 2026 | Oct 5, 2026 | Mid |
| Field Service Engineer II (Jackson/Memphis, TN) | Jackson/Memphis, TN | Sep 24, 2026 | Oct 5, 2026 | Mid |
| Design Control Program Manager (Temporary 9 months) | Tijuana, Baja California, Mexico | Sep 18, 2026 | Oct 5, 2026 | Mid |
| Area Sales Manager (Detroit / Indianapolis) | Detroit, Indiana | Sep 17, 2026 | Oct 5, 2026 | Mid |
| Sales Trainer | United States | Sep 15, 2026 | Oct 5, 2026 | Mid |
| Area Sales Manager (Washington DC / Baltimore) | Washington DC | Sep 15, 2026 | Oct 5, 2026 | Mid |
| Area Sales Manager (NYC) | New York City | Sep 15, 2026 | Oct 5, 2026 | Mid |
| Area Sales Manager (Minneapolis) | Minneapolis | Sep 15, 2026 | Oct 5, 2026 | Mid |
| Area Sales Manager (Miami) | Miami | Sep 15, 2026 | Oct 5, 2026 | Mid |
| Area Sales Manager (Los Angeles) | Los Angeles | Sep 15, 2026 | Oct 5, 2026 | Mid |
| Area Sales Manager (Denver / Salt Lake) | Denver | Sep 15, 2026 | Oct 5, 2026 | Mid |
| Field Service Engineer II (Sidney, OH) | Sidney, OH | Sep 8, 2026 | Oct 5, 2026 | Mid |
| Clinical Excellence Manager (California) | Remote | Aug 20, 2026 | Oct 5, 2026 | Mid |
| Field Service Engineer II (Seattle, WA) | Seattle, WA | Aug 19, 2026 | Oct 20, 2026 | Not stated |
| Field Service Engineer II (Freeport, IL) | Freeport, Illinois | Aug 12, 2026 | Oct 5, 2026 | Mid |
| Senior Microbiologist | San Jose, CA | Aug 11, 2026 | Oct 5, 2026 | Senior |
| Field Service Manager (Pacific Northwest) | Pacific Northwest, US | Aug 5, 2026 | Oct 5, 2026 | Mid |
| Clinical Excellence Manager | Denver, Colorado & Salt Lake City, UT | Jul 21, 2026 | Oct 5, 2026 | Mid |
| Field Service Engineer II (Dubuque, IA) | Dubuque IA | Jul 16, 2026 | Oct 5, 2026 | Mid |
| Area Sales Manager (Boston) | Boston | Jun 15, 2026 | Oct 5, 2026 | Mid |
| Quality Systems Specialist | Tijuana, Mexico | May 26, 2026 | Oct 5, 2026 | Mid |
| Area Sales Manager (Upper Midwest) | Chicago | May 8, 2026 | Oct 5, 2026 | Senior |
| Market Director (North East) | North East | Mar 17, 2026 | Oct 5, 2026 | Senior |
| Sales Training Program Manager | United States | Mar 3, 2026 | Oct 5, 2026 | Mid |
Funding
- Private placement: $168.8M (total, as published), announced Jan 6, 2025. Source: SEC filing. source ↗
Clinical trials (lead sponsor) 5
| Record | Title | Phase | Status | Start | Primary completion |
|---|---|---|---|---|---|
| NCT05947708 | The Study of Intradialytic Symptoms in Subjects Treated With Qd 500vs Qd 300 | Not phased (device or behavioral study) | Completed | Sep 15, 2019 | Oct 15, 2019 (actual) |
| NCT04526301 | Home With TablO outcoMEs (HOME) Registry | Not listed | Unknown status (ClinicalTrials.gov) | Jul 14, 2020 | Jul 31, 2024 (estimated) |
| NCT04912050 | EXtension of Tablo TrEatmeNt Duration Registry | Not listed | Completed | May 25, 2021 | May 31, 2022 (actual) |
| NCT04912024 | Comparative Outcome Measures of Patients Receiving Acute Renal ThErapy Study | Not listed | Completed | May 15, 2021 | Jun 15, 2022 (actual) |
| NCT02460263 | The EvAluation of TaBlo In-CLinic and In-HOme | Not phased (device or behavioral study) | Completed | 2015-12 | 2019-05 (actual) |
FDA records (last 2 years)
- FDA 510(k) clearance: Tablo Hemodialysis System (PN-0008000, PN-0006000U) — K253412, Jan 26, 2026. Applicant at approval: Outset Medical, Inc. source ↗
Connect
See your connections at Outset Medical on LinkedIn (search by name, results not checked)